[1]
“Chimeric Antigen Receptor (CAR) Immunotherapy for Natural Killer (NK) cells, therapeutic approaches and future perspectives in the oncological field: a systematic review of Synthesis Without Meta-analysis (SWIM)”, RSD, vol. 14, no. 8, p. e0514849317, Aug. 2025, doi: 10.33448/rsd-v14i8.49317.